NasdaqCM - Delayed Quote USD
Moolec Science SA (MLEC)
At close: November 6 at 4:00 PM EST
Research Analysis
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | -0.07 | -0.06 | -0.26 | -0.24 |
| Low Estimate | -0.07 | -0.06 | -0.26 | -0.24 |
| High Estimate | -0.07 | -0.06 | -0.26 | -0.24 |
| Year Ago EPS | -0.04 | -0.05 | -0.19 | -0.26 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | 1.31M | 1.31M | 6.64M | 8.63M |
| Low Estimate | 1.31M | 1.31M | 6.64M | 8.63M |
| High Estimate | 1.31M | 1.31M | 6.64M | 8.63M |
| Year Ago Sales | 1.74M | -- | 5.62M | 6.64M |
| Sales Growth (year/est) | -24.70% | -- | 18.00% | 30.00% |
Earnings History
| CURRENCY IN USD | 9/30/2023 | 12/31/2023 | 3/31/2024 | 6/30/2024 |
|---|---|---|---|---|
| EPS Est. | -0.04 | -0.07 | -0.07 | -0.06 |
| EPS Actual | -0.04 | -0.05 | -0.04 | -0.07 |
| Difference | 0 | 0.02 | 0.03 | -0.01 |
| Surprise % | 0.00% | 28.60% | 42.90% | -16.70% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.07 | -0.06 | -0.26 | -0.24 |
| 7 Days Ago | -0.07 | -0.06 | -0.26 | -0.24 |
| 30 Days Ago | -0.07 | -0.06 | -0.26 | -0.24 |
| 60 Days Ago | -0.06 | -0.06 | -0.24 | -0.11 |
| 90 Days Ago | -0.06 | -0.06 | -0.24 | -0.11 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | MLEC | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -75.00% | -- | -- | 5.40% |
| Next Qtr. | -20.00% | -- | -- | 12.70% |
| Current Year | -36.80% | -- | -- | 2.10% |
| Next Year | 7.70% | -- | -- | 12.30% |
| Next 5 Years (per annum) | -- | -- | -- | 11.06% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Upgrades & Downgrades
| Initiated | Maxim Group: Buy | 1/30/2024 |
Related Tickers
LSBPW LakeShore Biopharma Co., Ltd
0.0400
+23.08%
COEP Coeptis Therapeutics Holdings, Inc.
0.2078
+3.38%
HCWB HCW Biologics Inc.
0.4300
-0.67%
NRXBF NUREXONE BIOLOGIC INC
0.4850
+7.78%
LSB LakeShore Biopharma Co., Ltd
2.1700
+0.93%
PTIX Protagenic Therapeutics, Inc.
0.6000
-4.76%
INAB IN8bio, Inc.
0.3337
-9.57%
RNXT RenovoRx, Inc.
1.0400
0.00%
STOK Stoke Therapeutics, Inc.
13.25
+1.53%
PSTX Poseida Therapeutics, Inc.
2.7800
+4.51%